SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Gut microbiota drug biotransformation as a tool to unravel the mechanisms of metabolic microbiota-host interactions

This project aims to systematically study metabolic interactions between gut microbiota and hosts using drug biotransformation to improve understanding of microbiome-related health variations and drug responses.

Subsidie
€ 1.894.858
2023

Projectdetails

Introduction

The variability of the human gut microbiome (the entirety of microorganisms inhabiting the intestine) far exceeds human genome variability and has been connected to various aspects of human health. Although microbiome differences are often linked to altered metabolism, the current view on metabolic interactions between the microbiota and the host remains mostly descriptive due to several limiting factors.

Limitations in Current Research

  1. Correlative Analyses: Most sequencing-based human microbiome studies rely on correlative analyses between microbiome composition and human phenotypes.
  2. Incomplete Genome Annotations: These studies depend on largely incomplete microbial genome annotations and are not targeted to identify community-mediated functional traits.
  3. Metabolite Origins: Many metabolites can be both of microbial and human origin, making it conceptually and methodologically challenging to disentangle metabolic microbiota-host interactions.

Proposed Strategy

To overcome these limitations, I propose a systematic bottom-up strategy to mechanistically study metabolic microbiota-host interactions by harnessing the gut microbiota’s capacity to biotransform (chemically modify) drug molecules.

Rationale for Using Medical Drugs

The large chemical diversity and exogenous origin of medical drugs make them ideally suited for experimental in vitro and in vivo approaches to probe microbiota-host interactions in a controlled way.

Methodology

We will combine the following approaches:

  • High-throughput culturing protocols
  • Genetics
  • Metabolomics measurements
  • Genomics analyses
  • Gnotobiotic mouse work
  • Computational modeling

This combination aims to connect interpersonal differences in microbiome composition to differences in metabolic functions of individuals’ gut microbiota and ultimately link them to molecular host phenotypes.

Importance of the Project

Generating these mechanistic insights and transformational resources is essential to understand the fundamental principles of the microbiota-host relationship.

Medical Relevance

In addition, this project has direct medical relevance, as it provides actionable microbiome-based links to interpersonal differences in medical drug response, which remain a widespread problem in clinical practice.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.894.858
Totale projectbegroting€ 1.894.858

Tijdlijn

Startdatum1-5-2023
Einddatum30-4-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • EUROPEAN MOLECULAR BIOLOGY LABORATORYpenvoerder

Land(en)

Germany

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Resolving metabolic interactions between the gut microbiota and the host with multi-omics-based modelling

This project aims to systematically characterize gut bacteria interactions and their metabolic contributions to host health using experimental and computational methods, enabling targeted microbiota interventions.

ERC Starting...€ 1.499.323
2024
Details

Proteome-wide Functional Interrogation and Modulation of Gut Microbiome Species

This project aims to identify and manipulate gut microbiome protein functions using high-throughput proteomics to develop targeted therapies for restoring microbial health.

ERC Starting...€ 1.499.980
2023
Details

Gut microbiome-mediated activities of psychotropic drugs

This project aims to explore the role of gut microbiomes in the efficacy and side effects of psychotropic drugs, potentially revolutionizing personalized drug therapy for mental illnesses.

ERC Starting...€ 1.497.033
2024
Details

Microbial ecosystems biology in the human gut

This project aims to develop a comprehensive ecosystem model of child gut microbiota using multiomic data to predict and manipulate microbial responses for improved health interventions.

ERC Starting...€ 1.485.413
2023
Details

Dissection of the host-microbe crosstalk that controls metabolism and physiology in intestinal symbiosis

This project aims to explore the regulatory mechanisms of intestinal bacteria and their symbiotic relationship with hosts using Drosophila to enhance understanding of gut metabolism and health.

ERC Starting...€ 1.499.600
2023
Details
ERC Starting...

Resolving metabolic interactions between the gut microbiota and the host with multi-omics-based modelling

This project aims to systematically characterize gut bacteria interactions and their metabolic contributions to host health using experimental and computational methods, enabling targeted microbiota interventions.

ERC Starting Grant
€ 1.499.323
2024
Details
ERC Starting...

Proteome-wide Functional Interrogation and Modulation of Gut Microbiome Species

This project aims to identify and manipulate gut microbiome protein functions using high-throughput proteomics to develop targeted therapies for restoring microbial health.

ERC Starting Grant
€ 1.499.980
2023
Details
ERC Starting...

Gut microbiome-mediated activities of psychotropic drugs

This project aims to explore the role of gut microbiomes in the efficacy and side effects of psychotropic drugs, potentially revolutionizing personalized drug therapy for mental illnesses.

ERC Starting Grant
€ 1.497.033
2024
Details
ERC Starting...

Microbial ecosystems biology in the human gut

This project aims to develop a comprehensive ecosystem model of child gut microbiota using multiomic data to predict and manipulate microbial responses for improved health interventions.

ERC Starting Grant
€ 1.485.413
2023
Details
ERC Starting...

Dissection of the host-microbe crosstalk that controls metabolism and physiology in intestinal symbiosis

This project aims to explore the regulatory mechanisms of intestinal bacteria and their symbiotic relationship with hosts using Drosophila to enhance understanding of gut metabolism and health.

ERC Starting Grant
€ 1.499.600
2023
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

MicroBioDx: karakterisatie van microbioom-gastheer interacties

TenWise en Predica ontwikkelen de MicroBioD om de complexe samenstelling van micro-organismen te analyseren en gerichte behandelingen voor dysbiose te faciliteren.

Mkb-innovati...€ 143.080
2021
Details
Mkb-innovati...

MicroBioDx: karakterisatie van microbioom-gastheer interacties

TenWise en Predica ontwikkelen de MicroBioD om de complexe samenstelling van micro-organismen te analyseren en gerichte behandelingen voor dysbiose te faciliteren.

Mkb-innovatiestimulering Topsectoren R&D Samenwerking
€ 143.080
2021
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.